McMullan, Ciaran J.Schernhammer, Eva S.Rimm, Eric Bruce::0ab2926c8242f35e5a982e3cf59f4987::600Hu, Frank B.Forman, John P.2019-08-272013McMullan, Ciaran J., Eva S. Schernhammer, Eric B. Rimm, Frank B. Hu, and John P. Forman. 2013. “Melatonin Secretion and the Incidence of Type 2 Diabetes.” JAMA 309 (13): 1388. https://doi.org/10.1001/jama.2013.2710.0098-74841538-3598http://nrs.harvard.edu/urn-3:HUL.InstRepos:41263105Importance Loss-of-function mutations in the melatonin receptor are associated with insulin resistance and type 2 diabetes. Additionally, in a cross-sectional analysis of persons without diabetes, lower nocturnal melatonin secretion was associated with increased insulin resistance.Objective To study the association between melatonin secretion and the risk of developing type 2 diabetes.Design, Setting, and Participants Case-control study nested within the Nurses' Health Study cohort. Among participants without diabetes who provided urine and blood samples at baseline in 2000, we identified 370 women who developed type 2 diabetes from 2000-2012 and matched 370 controls using risk-set sampling.Main Outcome Measures Associations between melatonin secretion at baseline and incidence of type 2 diabetes were evaluated with multivariable conditional logistic regression controlling for demographic characteristics, lifestyle habits, measures of sleep quality, and biomarkers of inflammation and endothelial dysfunction.Results The median urinary ratios of 6-sulfatoxymelatonin to creatinine were 28.2 ng/mg (5%-95% range, 5.5-84.2 ng/mg) among cases and 36.3 ng/mg (5%-95% range, 6.9-110.8 ng/mg) among controls. Women with lower ratios of 6-sulfatoxymelatonin to creatinine had increased risk of diabetes (multivariable odds ratio, 1.48 [95% CI, 1.11-1.98] per unit decrease in the estimated log ratio of 6-sulfatoxymelatonin to creatinine). Compared with women in the highest ratio category of 6-sulfatoxymelatonin to creatinine, those in the lowest category had a multivariable odds ratio of 2.17 (95% CI, 1.18-3.98) of developing type 2 diabetes. Women in the highest category of melatonin secretion had an estimated diabetes incidence rate of 4.27 cases/1000 person-years compared with 9.27 cases/1000 person-years in the lowest category.Conclusions and Relevance Lower melatonin secretion was independently associated with a higher risk of developing type 2 diabetes. Further research is warranted to assess if melatonin secretion is a modifiable risk factor for diabetes within the general population. JAMA. 2013;309(13):1388-1396 www.jama.comen-USJournal Article2019-08-2710.1001/jama.2013.2710